| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 51.379 | 84.719 | 114.162 | 182.487 | 165.332 | 117.036 | 105.128 | 107.160 | 94.117 | 128.708 |
| Total Income - EUR | 53.006 | 85.135 | 114.595 | 184.647 | 165.394 | 117.565 | 105.832 | 107.412 | 94.129 | 132.746 |
| Total Expenses - EUR | 46.489 | 49.595 | 66.571 | 104.308 | 72.694 | 48.198 | 28.342 | 29.121 | 28.688 | 31.067 |
| Gross Profit/Loss - EUR | 6.517 | 35.540 | 48.025 | 80.340 | 92.700 | 69.367 | 77.489 | 78.291 | 65.441 | 101.680 |
| Net Profit/Loss - EUR | 4.935 | 34.689 | 46.733 | 78.493 | 91.046 | 68.429 | 76.457 | 77.437 | 64.519 | 97.777 |
| Employees | 0 | 4 | 4 | 4 | 4 | 3 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Urodiamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 40.888 | 28.882 | 24.205 | 16.116 | 13.760 | 12.323 | 8.282 | 7.233 | 5.617 | 3.285 |
| Current Assets | 33.832 | 21.656 | 68.650 | 121.547 | 84.239 | 106.765 | 115.049 | 129.415 | 66.909 | 115.395 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44 | 0 | 0 |
| Receivables | 15.650 | 10.049 | 7.699 | 45.790 | 44.071 | 7.854 | 11.233 | 52.395 | 5.350 | 9.374 |
| Cash | 18.183 | 11.608 | 60.951 | 75.758 | 40.168 | 98.911 | 103.816 | 76.977 | 61.559 | 106.021 |
| Shareholders Funds | 64.565 | 34.742 | 46.785 | 124.420 | 91.097 | 113.484 | 116.672 | 77.486 | 64.567 | 97.825 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 12.501 | 16.841 | 50.226 | 16.441 | 9.040 | 7.004 | 7.133 | 59.182 | 8.435 | 21.241 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Urodiamed Srl